HTRA1 and cerebral small vessel disease: Therefore, loss-of-function mutation HTRA1 results in the stimulation of TGF-β signaling, which is considered to be a key pathophysiological mechanism of CARASIL and HTRA1-related cerebral small vessel disease [139].